Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Freegold Intersects 2.72 g/t Au over 139.9 metres at Golden Summit (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Castle Biosciences Inc CSTL

Healthcare Medical Instruments & Supplies
Castle Biosciences, Inc. is a commercial-stage diagnostics company. The Company is focused on providing physicians and their patients with personalized, clinically actionable information to clinicians and their patients to inform treatment decisions and improve health outcomes. Its portfolio consists of tests for skin cancers, uveal melanoma, Barretts esophagus and mental health conditions. Its... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:CSTL)

Castle's Poster on DecisionDx®-SCC Selected as a "Late Breakers" Top Five Finalist for the Akamai Award, Recognizing the Best Posters at Maui Derm Hawaii 2025

Business Wire 4 days ago

Castle Biosciences Announces Preliminary Unaudited Fourth Quarter and Full-Year 2024 Results

Business Wire 9 days ago

Castle Biosciences Announces New York State Department of Health Approval of Its TissueCypher® Barrett's Esophagus Test

Business Wire January 6, 2025

Castle Biosciences Highlights Progress for its Pipeline Atopic Dermatitis Gene Expression Profile Test

Business Wire December 23, 2024

Castle Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Business Wire December 19, 2024

Independent Systematic Review and Meta-Analysis Attests to the Significant Risk Stratification Provided by Castle Biosciences' DecisionDx®-Melanoma Test, Contributing to Personalized Management of Patients with Melanoma

Business Wire December 12, 2024

Castle Biosciences to Present at the Piper Sandler 36th Annual Healthcare Conference

Business Wire November 20, 2024

Castle Biosciences Earns a Houston Chronicle Top Workplaces Award for the Fourth Consecutive Year

Business Wire November 19, 2024

Castle Biosciences to Present New Data Highlighting the Clinical Performance of DecisionDx®-Melanoma and MyPath® Melanoma at the American Society of Dermatopathology 61st Annual Meeting

Business Wire November 8, 2024
View More News ››

Opinion & Analysis (NDAQ:CSTL)

Castle Biosciences Shares Storm Higher After Quadrupling Q3 YoY Revenue

Streetwise Reports November 13, 2019
View More Opinion ››

Bullboard Posts (NDAQ:CSTL)

Castle Biosciences to Release Third Quarter 2024 Financial R

Breaking News: $CSTL Castle Biosciences to Release Third Quarter 2024 Financial Results and Host Conference Call on Monday, Nov. 4...
whytestocks - October 14, 2024

Study Finds DecisionDx&#xAE;-Melanoma Significantly Improves

Breaking News: $CSTL Study Finds DecisionDx&#xAE;-Melanoma Significantly Improves the Risk Stratification of Patients with Stage I...
whytestocks - February 26, 2024
View more Bullboard ››

Nextleaf Solutions Ltd

Nextleaf Solutions Ltd

Nextleaf is a federally regulated manufacturer and distributor of cannabis vapes and oils under its prohibition-era brand ...
View More »